Mr. Marcin Wojewodzic | Neuroscience | Interdisciplinary Research Excellence Award
Researcher at Norwegian Institute of Public Health, Norway.
🌍 Marcin Wojewodzic is a Polish molecular physiologist and senior researcher at the Cancer Registry of Norway. His expertise spans epigenetics, molecular epidemiology, and toxicology, with a strong focus on using omics and artificial intelligence for biomarker discovery and risk assessment. He has led numerous international projects, including studies on the epigenetic effects of cisplatin-based chemotherapy and the impact of environmental exposures like PFAS chemicals on cancer development. With 42 publications, he is a recognized expert in his field, frequently collaborating on high-impact global research initiatives.
Profile👤
Education 🎓
🎓Marcin Wojewodzic holds a Ph.D. in Molecular Physiology from the University of Oslo, Norway (2010). His education includes specialized courses in machine learning, bioinformatics, environmental genomics, and epigenetics from prestigious institutions like Heidelberg, Melbourne, and Oslo. He earned a Master’s in Biology from Jagiellonian University, Poland, with an Erasmus program at Wageningen University, Netherlands (2003). He also completed a full pedagogical education and advanced leadership training with distinction, equipping him for academic and research leadership.
Experience
🩺 Current Role: Senior Researcher at the Cancer Registry of Norway, focusing on molecular epidemiology and infections, with projects on cancer biomarkers and PFAS exposure. Previous Roles: Researcher at the Norwegian Institute of Public Health (2021–present), Postdoctoral Fellow at the Cancer Registry of Norway (2018–2021), and Bioinformatician at Oslo University Hospital (2016–2018). Marcin has also served as a Marie Skłodowska-Curie Fellow in the UK and held research fellowships in Norway and the USA.
Research Interests 🔬
🔬 Marcin’s research centers on epigenetics, molecular epidemiology, and toxicology, with a strong emphasis on biomarker discovery and the effects of environmental chemicals on cancer. He develops computational tools and applies omics technologies to uncover relationships between exposures, DNA methylation, and disease progression. His work has implications for precision medicine and public health, particularly in cancer risk assessment and treatment outcomes.
Awards and Honors 🏆
Conclusion